Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China

Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China

Primary central nervous system lymphoma (PCNSL) remains a disease with poor outcome and high recurrence rate. We retrospectively analyzed the clinical data of 243 immunocompetent patients with PCNSL in Beijing Tiantan Hospital. The median age of PCNSL patients was 57 years (range 10-95 years). For i...

Full description

Bibliographic Details
Main Authors: Xuefei Sun, Yuchen Wu, Ruixian Xing, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Yuedan Chen, Qing Liu, Wenyuan Lai, Junhong Li, Yaming Wang, Shengjun Sun, Chunji Gao, Nan Ji, Yuanbo Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Oncology
Subjects:
PCNSL = primary central nervous system lymphoma
HD-MTX
consolidation
chemoimmunotherapy
R-MAD regimen
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.792274/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.792274/full

Similar Items